Director/PDMR Shareholding
January 25 2008 - 11:32AM
UK Regulatory
RNS Number:6198M
Phoqus Pharmaceuticals PLC
25 January 2008
Phoqus Pharmaceuticals plc
Directors' share dealings
West Malling, UK, 25 January 2008: Phoqus Pharmaceuticals plc (AIM: PQS)
("Phoqus" or the "Company"), the drug development company, announces that on 23
January 2008, Dr Peter Johnson, Chief Financial Officer of Phoqus, transferred
106,706 ordinary shares ("Shares") in the Company to exercising option-holders
in his capacity as nominee shareholder.
As previously announced, share options granted by the Company on 3 November 2005
were to be satisfied by the transfer of Shares held by certain institutional
shareholders. In order to facilitate the transfer of Shares to option-holders,
some of the institutional shareholders transferred Shares to Dr Peter Johnson,
Chief Financial Officer, to hold the Shares as their nominee pending exercise of
the share options by the option-holders, after which he would transfer the
relevant Shares to the exercising option-holders.
Following the above transfer of 106,706 Shares to the exercising option-holders
on 23 January 2008, 2,537 Shares are now held by Dr Johnson in his capacity as
nominee, representing less than 0.01 per cent of the issued share capital of the
Company. Dr Johnson's beneficial ownership of Phoqus Shares remains unchanged
at 294,926 ordinary Shares, or 0.64 per cent of the issued share capital of the
Company.
Enquiries:
Phoqus Pharmaceuticals plc
Suzanne Smith, Company Secretary Tel: 01732 870227
Nomura Code Securities Limited
Phil Walker Tel: 020 7776 1200
This information is provided by RNS
The company news service from the London Stock Exchange
END
RDSEAXFSADFPEFE
Phoqus (LSE:PQS)
Historical Stock Chart
From Aug 2024 to Sep 2024
Phoqus (LSE:PQS)
Historical Stock Chart
From Sep 2023 to Sep 2024
Real-Time news about Phoqus (London Stock Exchange): 0 recent articles
More Phoqus Pharma News Articles